MoneyShow's Tom Aspray takes an in-depth look at his
successful Charts in Play Portfolio, as he looks to take profits on some
positions and close out others in order to reduce the equity exposure as the
stock market enters an uncertain period.

The deterioration in the daily technical outlook for the stock market over
the past week suggests we could see more choppy trading in the weeks ahead.

This does not change my longer-term positive view, and I still think we will
see a much stronger rally into the end of the year. But the market internals
currently reflect a level of risk that warrants a less fully invested position
in the stock market. When the NYSE href=""
target=_blank>Advance/Decline line signals that a major new
intermediate-term uptrend is underway, that will be the time to be more
aggressive in the stock market.

Currently, the "Charts in Play Portfolio" is about 68% invested in stocks and
ETFs, so now is a good time to examine the portfolio with the goal of lowering
the equity exposure. Instead of just adding my recommendations to the table
below, I thought it might be instructive to show you some of the specific
technical reasons why I am reducing or closing out certain positions.

Learning to critically examine one's portfolio can be an important process in
achieving long term success. So I hope you will find this discussion on
"portfolio pruning" beneficial.

Editor's Note: This Trading Lesson was written before the
surprising announcement Thursday by European Central Bank President Mario Draghi
that they would do whatever necessary to preserve the Euro. This has boosted all
of the world equity markets...but one day's action is not enough to reverse the
recent href=""
target=_blank>deterioration in the market internals that I discussed
Tuesday. Even though this action could resurrect the market's uptrend, I prefer
to act on hard data, not expectations.

href="#"> src="">

Click to Enlarge

The chart above shows the current holdings of the Charts in Play Portfolio,
and I have added a column for current yield, as the yield will play a role in
what type of action I may recommend for any particular holding.

Next: Technology


Of course, with the release of its earnings this week, Apple
( target=_blank>AAPL) and the technology sector are getting lots of attention,
so I will start with this sector.

Apple ( href=""
target=_blank>AAPL) traded as low as $570.51 on Wednesday after its earnings
were released, but was as low as $565 in after-hours trading Tuesday.

href="#"> src="">

Click to Enlarge

The weekly chart shows that the $565 to $567 level (20-week EMA) is an
important level of short-term support. The major 38.2% support is at $516.31,
with further chart support in the $490 to $500 area.

The weekly href=""
target=_blank>relative performance is now just below its WMA, but well above
its long term support (line a). The weekly href=""
target=_blank>on-balance volume (OBV) is also below its WMA, but volume was
strong early in the year, so the OBV is well above its longer-term uptrend (line

Given the long-term prospects for AAPL, I am willing to give this position
some room. As a rule, I do not like to have a profit turn into a loss, but am
making an exception for AAPL. On longs from $567.80, use a stop at $564.80. If
we are stopped out, a drop back to the major 38.2% support is not out of the

We also have a long position in the Select Spyder SPDR
( href=""
target=_blank>XLK) from $28.22. XLK has a 19% weighting in AAPL, 8% in MSFT,
7% in T and 4% in INTC- all stocks that are part of the current Charts in Play
Portfolio. The key support for XLK is in the $27.63 area (line d), which
corresponds to the late June low.

The daily relative performance is in a downward trading range, but has formed
higher highs over the longer term (line e). The OBV bottomed in June, and is
still holding above its support (line g). A break of this support could trigger
a decline to the $25.50 to $26 area.

href="#"> src="">

Click to Enlarge

Also in the tech sector is Automatic Data Processing ( href=""
target=_blank>ADP), where we are long from $53.98. It closed Wednesday at
$55.41. ADP traded as high as $56.97 last week, and tested trend line resistance
(line a). The heavy-volume trading on last Friday's weak close set the stage for
Monday's down-gap opening.

The relative performance is still in its uptrend and positive. The daily OBV
has dropped well below its WMA which is now flattening out. This may be a sign
of further weakness.

While the semiconductor stocks do appear to be bottoming, a very heavy
exposure in any one sector is only justifiable when the overall stock market is
trending strongly. Given the recent action, the market may not start to trend
higher until later in the summer.

target=_blank>New longs were recently added in the Market Vectors
Semiconductor ETF
( href=""
target=_blank>SMH) at an average price of $30.74. This ETF has a 19% holding
in Intel ( href=""
target=_blank>INTC), but I like the technical action of SMH better.

The weekly chart of Intel ( href=""
target=_blank>INTC) shows the major breakout above resistance in early 2012
(line d). INTC rallied to a high of $29.72 in May and tested long-term
resistance from 2005 (line c).

The RS analysis turned positive ahead of prices last fall, but has broken its
uptrend (line e) in the past two months. The weekly OBV has been below its WMA
since mid-May, and has continued to move lower. It is still above longer-term
support (line f).

In addition, we are also holding long positions in three other semiconductor
stocks: Spansion ( href=""
target=_blank>CODE), Microchip Tech ( title=
target=_blank>MCHP), and NVIDIA ( title=

Technology Sector Recommendations: I recommend closing out
the entire long positions in Automatic Data Processing (ADP)
and Spansion ( href=""
target=_blank>CODE). I would close out half of the position in
Intel ( href=""
target=_blank>INTC) and use a tight stop on the remaining position.

Next: Health Care

Health Care

target=_blank>As I noted last Friday, the weekly technical view of the
Select Sector SPDR Health Care ( href=""
target=_blank>XLV) ETF still looks strong.

There are currently six health-care stocks in the portfolio, and the two
largest positions are iShares Nasdaq Biotechnology ( href=""
target=_blank>IBB) and Bristol-Myers Squibb ( href=""
target=_blank>BMY), which are up 12% and 13% respectively.

href="#"> src="">

Click to Enlarge

The weekly chart of Bristol-Myers Squibb ( href=""
target=_blank>BMY) shows that it came very close to its weekly href=""
target=_blank>Starc+ band just two weeks ago, hitting a high of $36.34. Our
recommended long positions were established at $31.98, and it yields 3.9%.

There is next support at $33.80, with the 38.2% href=""
target=_blank>Fibonacci retracement support from the August 2011 lows at
$32.29. The weekly Starc- band is currently at $32.56.

The relative performance did not confirm the recent highs, as it formed lower
highs (line a). The RS line is still holding above its long-term uptrend (line
b). The weekly OBV is also acting weaker than prices, as it has formed lower
highs (line c). A break of support (line d) would be more negative.

Abbott Laboratories ( href=""
target=_blank>ABT) is acting better that BMY, but is also overextended, as
it came very close to its weekly Starc+ band last week (see arrow). Our
recommended long positions were established at $60.81, and it yields 3.2%.

The rising 20-week EMA has acted as good support, and is currently at $61.62.
The long-term chart shows that ABT staged a major breakout early in the year
when it surpassed the resistance (line e) in the $59 area.

The relative performance overcame long-term resistance (line f) and has
confirmed the recent highs. The volume has been strong over the past two weeks,
and the OBV has continued to act stronger than prices after it broke through
long-term resistance (line g).

Other health-care stocks in the portfolio include in Amgen
( target=_blank>AMGN), Pfizer ( href=""
target=_blank>PFE) and Eli Lilly ( href=""

Health Sector Recommendations: Sell half of the positions in
both Bristol-Myers Squibb ( href=""
target=_blank>BMY) and Abbott Laboratories ( href=""
target=_blank>ABT). Stops have also been adjusted in the other health care

Next: REITs


Two of my REIT holdings look vulnerable on a short-term basis, and are
nearing a seasonally weak period.

The weekly chart of SL Green Realty ( href=""
target=_blank>SLG) shows that it has formed lower highs (line a), suggesting
the recent rally was part of a continuation pattern. Our recommended long
positions were established at $72.11, and it yields 1.3%.

href="#"> src="">

Click to Enlarge

There is next support in the $73 to $73.30 area, with major support in the
$70 area (line b). The weekly RS line has dropped back below its WMA, and could
test longer-term support (line d).

The weekly OBV has formed lower highs (line e) and has dropped back below its
WMA. The daily OBV is below its WMA, suggesting that a further pullback is

The Taubman Centers ( href=""
target=_blank>TCO) also has turned lower after challenging the recent highs
in the $79.70 to $80.69 area (line f). Our recommended long positions were
established at $71.34, and it yields 2.4%.

The recent trading range (lines f and g) is likely to eventually be resolved
to the upside, but a test of the $70 to $72 area is possible first. The relative
performance is still in a strong uptrend (line h), and is acting stronger than

The weekly OBV has formed slightly lower highs (line i), though it is trying
to move back above its WMA. The daily OBV is still below its declining WMA.

We are also long in Camden Property Trust ( href=""
target=_blank>CPT) from $63.33, and it currently has over a 12% gain. It
also has a much more attractive yield at 3.2%

REIT Recommendations: I recommend closing out half of the
positions in SL Green Realty ( href=""
target=_blank>SLG) and Taubman Centers ( href=""
target=_blank>TCO). As per the Charts In Play Portfolio page, I have raised
the stops on the remaining position to lock in a profit.

Consumer Staples & Retail

Consumer Staples & Retail

As I discussed in last week's column, the chart of the Select Sector
SPDR Consumer Staples
( href=""
target=_blank>XLP) did show some signs that it was losing upside

This ETF has over 10% in Coca-Cola ( href=""
target=_blank>KO), Procter & Gamble ( href=""
target=_blank>PG), and Philip Morris ( href=""
target=_blank>PM). It also has over 4% in Kraft Foods ( href=""
target=_blank>KFT), which was stopped out of the portfolio this week. I
would hold onto the ETF, since it gives the portfolio some further

href="#"> src="">

Click to Enlarge

The daily chart of HJ Heinz ( href=""
target=_blank>HNZ) shows a broad trading range (lines a and b) so far in
2012. Our recommended long positions were established at $52.63, and it yields

The relative performance has formed lower highs (line c), and it is well
below the highs seen last year. The daily OBV has also formed lower highs (line
d), and has just dropped below its WMA. The weekly OBV (not shown) does look
more positive.

The retail sector typically bottoms out in the late summer or early fall, but
on July 11, href=""
target=_blank>I saw signs of bottoming and recommended SPDR S&P
Retail ETF
( href=""
target=_blank>XRT), Macy's ( href=""
target=_blank>M), and Dillard's ( href=""

Macy's ( href=""
target=_blank>M) is already up almost 10%, while SPDR S&P Retail
( href=""
target=_blank>XRT) is flat. Our longs in Dillard's ( href=""
target=_blank>DDS) were recommended at $63.34, and it closed at $62.93 on
July 25.

The daily chart shows that DDS has formed a series of lower highs (line f),
with important support in the $61 area (line g). A break of this support could
drop DDS back to more important support in the $55 to $57 area. The company
reports earnings on August 6.

The daily RS has also formed lower highs, and is also not far above its
support (line h). A drop below this level could precede a break in prices. The
daily OBV is trading in a narrow range, but holding above support (line i).

Consumer Staples & Retail Recommendations: Since our
longs were established in HJ Heinz ( href=""
target=_blank>HNZ) near the lower end of its range, and because of its high
yield, I would recommend selling just half of the position. Dillard's ( href=""
target=_blank>DDS) is another story, and I would sell the entire

These changes in the portfolio will reduce the equity exposure in the Charts
in Play Portfolio by about 14%, to what I feel the appropriate exposure for the
current market. If the market drops further, the equity exposure will decline
even further.

There are, of course, quite a few positions that I have not discussed, and
the majority of these look quite positive technically. Gold prices have bounced
recently, suggesting that the seasonal low may be in place. Still, we need
higher prices and stronger volume to confirm an important low for gold. Stay

I will be continuing to adjust the positions in the portfolio, and suggest
that you follow my feed on Twitter @TradersExpo and @TomAspray for additional
changes in our position. For the portfolio record, I will be using the opening
prices on Friday, July 27 for any new recommendations in the Trading